Trial Outcomes & Findings for European Mortality & Length Of Intensive Care Unit (ICU) Stay Evaluation (ELOISE) (NCT NCT01422070)
NCT ID: NCT01422070
Last Updated: 2015-08-21
Results Overview
Hospital mortality of the patients admitted to intensive care units with or without intermediate care unit in the hospital
COMPLETED
6433 participants
Max 90 days after admission to the Study Unit
2015-08-21
Participant Flow
All admissions of patients aged ≥ 16 years to a study during 28-day period (from 7 Nov to 4 Dec 2011, or from 16 Jan to 12 Feb 2012), excludind admissions only for organ donation, and with any limitation of care stated before unit admission. Maximum number of admissions per unit was 100.
Prospective observational study, without group assignment. Study units gave information about organization. 32 admissions to units with level of care lower than intensive care unit (ICU), 337 readmissions, 83 admissions out of the dates of enrollment slots, and 147 admissions with unknown vital status at hospital discharge were excluded.
Participant milestones
| Measure |
Units in Hospitals With Intermediate Care Unit
Adult patients consecutively admitted to Intensive Care Units in hospitals with intermediate care unit
|
Units in Hospitals Without Intermediate Care Unit
Adult patients consecutively admitted to Intensive Care Units in hospitals without intermediate care unit
|
|---|---|---|
|
Overall Study
STARTED
|
5031
|
803
|
|
Overall Study
COMPLETED
|
5031
|
803
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
European Mortality & Length Of Intensive Care Unit (ICU) Stay Evaluation (ELOISE)
Baseline characteristics by cohort
| Measure |
Units With Intermediate Care Unit
n=5031 Participants
Patients admitted to intensive care unit with intermediate care unit in the hospital
|
Units Without Intermediate Care Unit
n=803 Participants
Patients admitted to intensive care unit without intermediate care unit in the hospital
|
Total
n=5834 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
65 years
n=99 Participants
|
68 years
n=107 Participants
|
65 years
n=206 Participants
|
|
Sex: Female, Male
Female
|
2002 Participants
n=99 Participants
|
332 Participants
n=107 Participants
|
2334 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
3029 Participants
n=99 Participants
|
471 Participants
n=107 Participants
|
3500 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: Max 90 days after admission to the Study UnitHospital mortality of the patients admitted to intensive care units with or without intermediate care unit in the hospital
Outcome measures
| Measure |
Units in Hospitals With Intermediate Care Unit
n=5031 Participants
Patients admitted to intensive care unit with intermediate care unit in the hospital
|
Units in Hospitals Without Intermediate Care Unit
n=803 Participants
Patients admitted to intensive care unit without intermediate care unit in the hospital
|
|---|---|---|
|
Vital Status at Hospital Discharge
|
1232 participants
|
165 participants
|
SECONDARY outcome
Timeframe: Max 90 days after admission to intensive care unitNumber of days (calendar days -1) from admission to and discharge from the Study Unit
Outcome measures
| Measure |
Units in Hospitals With Intermediate Care Unit
n=5031 Participants
Patients admitted to intensive care unit with intermediate care unit in the hospital
|
Units in Hospitals Without Intermediate Care Unit
n=803 Participants
Patients admitted to intensive care unit without intermediate care unit in the hospital
|
|---|---|---|
|
Length of ICU Stay
|
3.7 days
Interval 1.9 to 7.7
|
2.8 days
Interval 1.8 to 4.8
|
SECONDARY outcome
Timeframe: Max 90 days after admission to the Study UnitNumber of days (calendar days -1) from admission to the Study Unit to discharge from the hospital
Outcome measures
| Measure |
Units in Hospitals With Intermediate Care Unit
n=5031 Participants
Patients admitted to intensive care unit with intermediate care unit in the hospital
|
Units in Hospitals Without Intermediate Care Unit
n=803 Participants
Patients admitted to intensive care unit without intermediate care unit in the hospital
|
|---|---|---|
|
Length of Hospital Stay
|
13.9 days
Interval 7.6 to 25.0
|
11.0 days
Interval 6.2 to 11.0
|
SECONDARY outcome
Timeframe: Max 90 days after admission to the Study UnitNumber of readmissions to intensive care unit during the same hospital course
Outcome measures
| Measure |
Units in Hospitals With Intermediate Care Unit
n=5031 Participants
Patients admitted to intensive care unit with intermediate care unit in the hospital
|
Units in Hospitals Without Intermediate Care Unit
n=803 Participants
Patients admitted to intensive care unit without intermediate care unit in the hospital
|
|---|---|---|
|
Number of ICU Readmissions
|
292 readmissions
|
40 readmissions
|
Adverse Events
Adverse Events Not Collected
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place